PlainPharmaWatch

CMS Open Payments · Tool

Exo Imaging, Inc. vs IlluminOss Medical, Inc.

Side-by-side comparison of CMS Open Payments data for Program Year 2024. Select different companies below to start a new comparison.

A larger reported total is not "better" or "worse", it is a neutral fact about disclosure volume; a reported payment documents a financial relationship, not evidence of wrongdoing.

Compare Different Companies

vs

Relationship comparison

Which recorded payment profile is more concentrated?

IlluminOss Medical, Inc. has the more concentrated recorded General Payments recipient profile in Program Year 2024: its recipient-distribution HHI is 583, versus 233 for the other company. Its single largest recorded recipient represents 17.6% of that company's General Payments recipient total.

HHI summarizes how payments are distributed across recorded recipients: higher means a less evenly distributed recipient pattern. This is a description of CMS-reported General Payments only, not a finding about conduct, prescribing, quality, or wrongdoing. Read it with the recipient count and underlying records below.

Exo Imaging, Inc.
HHI 233 · top recipient 11.3%
Ranked #1,527 of 1,838 companies by HHI
IlluminOss Medical, Inc.
HHI 583 · top recipient 17.6%
Ranked #1,240 of 1,838 companies by HHI

Payment Overview

Company A

Exo Imaging, Inc.

Total Payments
$292.7K
% of Industry
0.0%
Transactions
175
Avg per Transaction
$1.7K
Recipients
175
Avg per Recipient
$1.7K
Payment Types
4
Top Payment Type
Long-Term Medical Supply or Device Loan
Total Payments
$293.7K
% of Industry
0.0%
Transactions
486
Avg per Transaction
$604.28
Recipients
469
Avg per Recipient
$626.18
Payment Types
5
Top Payment Type
Honoraria

Highlighted values indicate the higher figure for each metric.

Total payments compared

Exo Imaging, Inc. vs IlluminOss Medical, Inc. - total reported payments in CMS Open Payments PY2024

IlluminOss Medical, Inc.$293.7KExo Imaging, Inc.$292.7K

General Payment Types Breakdown

Category shares use each company's General Payments total, not the all-tracks (General + Research + Ownership) hero figure.

Exo Imaging, Inc.

Long-Term Medical Supply or Device Loan $234.5K

80.1%

Consulting Fee $54.6K

18.7%

Gift $3.4K

1.2%

Food and Beverage $165.92

0.1%

IlluminOss Medical, Inc.

Honoraria $57.6K

34.1%

Consulting Fee $54.3K

32.2%

Education $28.0K

16.6%

Food and Beverage $23.0K

13.6%

Travel and Lodging $5.9K

3.5%

Top 5 General-Payment Recipients

This list uses CMS detailed General Payments records only; it excludes research and ownership/investment records, so it does not equal the all-category totals above. A reported payment documents a financial relationship, not evidence of wrongdoing; a higher total reflects reporting volume, not conduct. Verify directly at openpaymentsdata.cms.gov.

Exo Imaging, Inc.

  1. 1

    Richard Louis Popp

    $33,150.00 · 6 txns

  2. 2

    Diku Mandavia

    $4,947.00 · 4 txns

  3. 3

    Emily Lovallo

    $4,250.00 · 3 txns

  4. 4

    Brandon Joel Boesch

    $4,200.00 · 3 txns

  5. 5

    Trevor P Jensen

    $3,950.00 · 3 txns

IlluminOss Medical, Inc.

  1. 1

    WILLIAM HARTMAN HARVIN

    $29,681.60 · 15 txns

  2. 2

    KYLE MOBLEY

    $13,392.38 · 4 txns

  3. 3

    CHRISTOPHER BORN

    $10,790.00 · 3 txns

  4. 4

    JAMES DANIEL HLAVACEK

    $8,125.47 · 7 txns

  5. 5

    BROOKE M. CRAWFORD

    $7,901.36 · 7 txns

Summary Comparison

Metric Exo Imaging, Inc. IlluminOss Medical, Inc.
Total Payments $292.7K $293.7K
% of Industry Total 0.0% 0.0%
Transaction Count 175 486
Avg per Transaction $1.7K $604.28
Recipient Count 175 469
Avg per Recipient $1.7K $626.18
Payment Type Count 4 5
Top Payment Type Long-Term Medical Supply or Device Loan Honoraria

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. All companies in the CMS Open Payments company corpus are available in the selector. Browse all companies →

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.